<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s12879-019-4395-3</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">12879</journal-id><journal-title-group><journal-title>BMC Infectious Diseases</journal-title><abbrev-journal-title abbrev-type="publisher">BMC Infect Dis</abbrev-journal-title></journal-title-group><issn pub-type="epub">1471-2334</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s12879-019-4395-3</article-id><article-id pub-id-type="manuscript">4395</article-id><article-id pub-id-type="doi">10.1186/s12879-019-4395-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="article-collection" specific-use="SubjectSection"><subject>Bacterial and fungal diseases</subject></subj-group></article-categories><title-group><article-title xml:lang="en">High incidence of virulence determinants, aminoglycoside and vancomycin resistance in enterococci isolated from hospitalized patients in Northwest Iran</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Haghi</surname><given-names>Fakhri</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Lohrasbi</surname><given-names>Vahid</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au3"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7467-1147</contrib-id><name><surname>Zeighami</surname><given-names>Habib</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="corresp" rid="IDs1287901943953_cor3">c</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0612 8427</institution-id><institution-id institution-id-type="GRID">grid.469309.1</institution-id><institution content-type="org-division">Department of Microbiology, School of Medicine</institution><institution content-type="org-name">Zanjan University of Medical Sciences</institution></institution-wrap><addr-line content-type="city">Zanjan</addr-line><country country="IR">Iran</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0612 8427</institution-id><institution-id institution-id-type="GRID">grid.469309.1</institution-id><institution content-type="org-division">Zanjan Pharmaceutical Biotechnology Research Center</institution><institution content-type="org-name">Zanjan University of Medical Sciences</institution></institution-wrap><addr-line content-type="city">Zanjan</addr-line><country country="IR">Iran</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 4911 7066</institution-id><institution-id institution-id-type="GRID">grid.411746.1</institution-id><institution content-type="org-division">Department of Microbiology</institution><institution content-type="org-name">Iran University of Medical Sciences</institution></institution-wrap><addr-line content-type="city">Tehran</addr-line><country country="IR">Iran</country></aff></contrib-group><author-notes><corresp id="IDs1287901943953_cor3"><label>c</label><phone>+982433140296</phone><email>zeighami@zums.ac.ir</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>8</month><year>2019</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2019</year></pub-date><volume>19</volume><issue seq="744">1</issue><elocation-id>744</elocation-id><history><date date-type="registration"><day>21</day><month>8</month><year>2019</year></date><date date-type="received"><day>24</day><month>6</month><year>2019</year></date><date date-type="accepted"><day>20</day><month>8</month><year>2019</year></date><date date-type="online"><day>27</day><month>8</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s). 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="url">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><sec id="ASec1"><title>Background</title><p id="Par1">Multidrug resistant (MDR) enterococci are important nosocomial pathogens causing serious problem in hospitalized patients. The aim of present study was to investigate the frequency of high-level aminoglycoside-resistant and vancomycin-resistant enterococci (VRE) and virulence encoding genes in enterococci isolated from hospitalized patients.</p></sec><sec id="ASec2"><title>Methods</title><p id="Par2">A total of 100 enterococci isolated from urine samples of hospitalized patients with symptomatic urinary tract infections were investigated for antimicrobial susceptibility, the frequency of aminoglycoside and vancomycin resistance genes (including <italic>aac (6′)-Ie-aph (2“)-Ia, aph (3’)-IIIa, ant (4’)-Ia, aph (2”)-Ic, aph (2“)-Ib, aph (2”)-Id, ant (3″)-III, ant (6′)-Ia, vanA, vanB</italic> and <italic>vanC</italic>) and virulence encoding genes (including <italic>gelE, PAI, esp, ace, cyl, hyl</italic> and <italic>sprE</italic>).</p></sec><sec id="ASec3"><title>Results</title><p id="Par3"><italic>Enterococcus faecalis</italic> species was identified as predominant enterococci (69%), followed by “other” <italic>Enterococcus</italic> species (21%) and <italic>E. faecium</italic> (10%). Ninety three percent of isolates were resistant to one or more antimicrobial agents, with the most frequent resistance found against tetracycline (86%), ciprofloxacin (73%) and quinupristin-dalfopristin (53%). Gentamicin and streptomycin resistance were detected in 50 and 34% of isolates, respectively. The most prevalent aminoglycoside resistance genes were <italic>ant (3″)-III</italic> (78%) and <italic>aph (3′)-IIIa</italic> (67%). Vancomycin resistance was detected in 21% of isolates. All <italic>E. faecium</italic> isolates carried <italic>vanA</italic> gene, whereas, the <italic>vanB</italic> gene was not detected in <italic>Enterococcus</italic> species. The most frequent virulence gene was <italic>ace</italic> (88.6%), followed by <italic>esp</italic> (67.1%), <italic>PAI</italic> (45.5%) and <italic>sprE</italic> (41.7%).</p></sec><sec id="ASec4"><title>Conclusion</title><p id="Par4">Our study revealed the high frequency of gentamycin resistance and VRE in <italic>E. faecium</italic> isolates, with a high prevalence and heterogeneity of virulence and resistance genes. Due to high frequency of MDR enterococci, it seems that the appropriate surveillance and control measures are essential to prevent the emergence and transmission of these isolates in hospitals.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Aminoglycoside resistance</kwd><kwd>Enterococci</kwd><kwd>Vancomycin resistance</kwd><kwd>Virulence factors</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>2</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>No</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>8</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>21</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/12879_2019_Article_4395.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Medicine &amp; Public Health</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Infectious Diseases</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Parasitology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Medical Microbiology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Tropical Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Internal Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Medicine</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par15">Enterococci are the second most common causative agent of urinary tract infections (UTIs) in hospitalized patients [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Antimicrobial resistance and survival ability in various hospital environments have made them as serious problem in nosocomial infections due to the limited therapeutic options [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. The inherent antibiotic resistance and dissemination of resistance genes through conjugative transposons and plasmids play an important role in development of multidrug resistant (MDR) enterococci [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par16">Aminoglycosides alone are considered inactive in the treatment of enterococcal infections and are usually combined with inhibitors of cell wall synthesis such as vancomycin or ampicillin [<xref ref-type="bibr" rid="CR6">6</xref>]. High-level aminoglycoside-resistant (HLAR) and vancomycin-resistant enterococci (VRE) have created serious problems for antibiotic therapy [<xref ref-type="bibr" rid="CR6">6</xref>]. Vancomycin-resistant enterococci are more common in North America, Europe, and Asia. Eight genotypes (<italic>vanA, vanB, vanC, vanD</italic>, <italic>vanE</italic>, <italic>vanG, vanM</italic> and <italic>vanL</italic>) have been described, of which, <italic>vanA</italic> (Tn1546) genotype with acquired inducible resistance to vancomycin and teicoplanin and <italic>vanB</italic> (Tn1549/Tn5382) genotype with variable resistance to vancomycin and susceptibility to teicoplanin are the most common [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par17">High level aminoglycoside resistance is due to acquisition of genes encoding the aminoglycoside modifying enzymes (AMEs) such as aminoglycoside phosphoryl transferase (APH), aminoglycoside acetyl transferase (AAC) and aminoglycoside nucleotidyl transferase (ANT) [<xref ref-type="bibr" rid="CR8">8</xref>]. The high level gentamicin resistance (HLGR, MIC≥500 μg/ml) is commonly due to <italic>aac (6′)-Ie-aph (2″)-Ia</italic>, which is located on the Tn5281 transposon and encodes a bifunctional enzyme, AAC (6′)-APH (2″) [<xref ref-type="bibr" rid="CR8">8</xref>]. Recently, aminoglycoside modifying genes <italic>aph (2″)-Ib, aph (2″)-Ic,</italic> and <italic>aph (2″)-Id</italic> were detected among enterococci [<xref ref-type="bibr" rid="CR9">9</xref>]. These genes are associated with high levels gentamicin resistance. Moreover, high-level streptomycin resistance (HLSR, MIC ≥2000 μg/ml) is mediated by <italic>aph (3′)-IIIa</italic> and <italic>ant (6′)-Ia</italic> genes [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par18">Enterococci possess virulence genes including <italic>ace</italic>, <italic>PAI</italic>, <italic>asa1</italic>, <italic>sprE</italic>, <italic>cylA</italic>, <italic>efaA</italic>, <italic>esp</italic>, <italic>gelE</italic> and <italic>hyl</italic> encoding collagen-binding protein, pathogenicity islands, aggregation substance, serine protease, cytolysin, endocarditis antigen, enterococcal surface protein, gelatinase and hyaluronidase, respectively [<xref ref-type="bibr" rid="CR1">1</xref>]. The gelatinase is an extracellular metalloprotease that hydrolyzes collagen, gelatin, and small peptides [<xref ref-type="bibr" rid="CR10">10</xref>]. The enterococcal cytolysin is a member of bacteriocin family which lyses bacterial and eukaryotic cells in response to quorum sensing signals [<xref ref-type="bibr" rid="CR11">11</xref>]. The enterococcal surface protein seems to contribute in the colonization and persistence of enterococci in ascending infections of the urinary tract and biofilm formation. Hyaluronidase is an important factor in nasopharyngeal colonization and pneumonia [<xref ref-type="bibr" rid="CR10">10</xref>]. Recent studies showed the association between the presence of virulence factors and promoting emergence of enterococcal infections in nosocomial settings [<xref ref-type="bibr" rid="CR5">5</xref>]. However, our knowledge about the possible relationship between the presence of virulence factors and their role in the emergence and development of resistance among enterococci is still limited [<xref ref-type="bibr" rid="CR2">2</xref>]. Previous studies revealed that antimicrobial resistance and virulence are two different aspects of bacterial cell fitness and increased antimicrobial resistance might not always be associated with increased virulence [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par19">Regarding the emergence of MDR enterococci have become a serious problem in hospitalized patients, the present study aimed to investigate the frequency of HLAR and VRE strains, antibiotic susceptibility, the frequency of AME and Van genes (including <italic>aac (6′)-Ie-aph (2“)-Ia, aph (3’)-IIIa, ant (4’)-Ia, aph (2”)-Ic, aph (2“)-Ib, aph (2”)-Id, ant (3″)-III, ant (6′)-Ia, vanA, vanB</italic> and <italic>vanC</italic>) and virulence encoding genes (including <italic>gelE, PAI, esp, ace, cyl, hyl</italic> and <italic>sprE</italic>) in enterococci isolated from urine samples.</p></sec><sec id="Sec2" sec-type="methods"><title>Methods</title><sec id="Sec3"><title>Bacterial isolation and identification</title><p id="Par20">Between March 2016 and February 2017, 1 hundred enterococci were isolated from urine samples of hospitalized patients with symptomatic urinary tract infections (UTIs) at least 48 h after hospital admission from three major hospitals in Zanjan, Iran. Informed consent and ethical approval was obtained from management of the hospitals prior to the study. The symptomatic UTI criteria consisted of dysuria, suprapubic pain or tenderness, urgency and frequency of micturition. The exclusion criteria for patients were fever, nausea, vomiting and mixed infection. Catheter urine samples were also excluded from our study. Laboratory confirmed UTI was defined as pyuria (&gt; 10 WBC/mm<sup>3</sup> per high-power field) plus bacteriuria (≥10<sup>5</sup> cfu/mL). Urine samples were cultured on blood agar (Merck, Germany) and incubated under aerobic conditions at 37 °C for 24 h. Identification of isolates to the genus level was performed using Gram staining and biochemical tests. Species-level identification was performed by PCR targeting the <italic>ddl</italic> genes encoding D-alanine–D-alanine ligases specific for <italic>E. faecalis</italic> (<italic>ddl</italic><sub><italic>E.faecalis</italic></sub>) and <italic>E. faecium</italic> (<italic>ddl</italic><sub><italic>E.faecium</italic></sub>) (The primers are shown in Table <xref rid="Tab1" ref-type="table">1</xref>). Verified enterococci were preserved at − 70 °C for further analysis. All Microbiological and molecular tests were performed in department of Microbiology, Zanjan University of Medical Sciences, Zanjan, Iran.
<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Primers sequence and annealing tempratures used in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Target</p></th><th><p>Primer sequence (5′ → 3′)</p></th><th><p>Amplicon size (bp)</p></th><th><p>Annealing tempreture</p></th><th><p>Ref.</p></th></tr></thead><tbody><tr><td rowspan="2"><p><italic>ddl</italic><sub><italic>faecalis</italic></sub></p></td><td><p>ATCAAGTACAGTTAGTCTTTATTAG</p></td><td rowspan="2"><p>941</p></td><td rowspan="2"><p>55 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR13">13</xref>]</p></td></tr><tr><td><p>ACGATTCAAAGCTAACTGAATCAGT</p></td></tr><tr><td rowspan="2"><p><italic>ddl</italic><sub><italic>faecium</italic></sub></p></td><td><p>TTGAGGCAGACCAGATTGACG</p></td><td rowspan="2"><p>658</p></td><td rowspan="2"><p>55 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR13">13</xref>]</p></td></tr><tr><td><p>TATGACAGCGACTCCGATTCC</p></td></tr><tr><td rowspan="2"><p><italic>van A</italic></p></td><td><p>CATGAATAGAATAAAAGTTGCAATA</p></td><td rowspan="2"><p>1030 bp</p></td><td rowspan="2"><p>54 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR14">14</xref>]</p></td></tr><tr><td><p>CCCCTTTAACGCTAATACGATCAA</p></td></tr><tr><td rowspan="2"><p><italic>van B</italic></p></td><td><p>GTGACAAACCGGAGGCGAGGA</p></td><td rowspan="2"><p>433 bp</p></td><td rowspan="2"><p>54 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR14">14</xref>]</p></td></tr><tr><td><p>CCGCCATCCTCCTGCAAAAAA</p></td></tr><tr><td rowspan="2"><p><italic>van C</italic></p></td><td><p>GAAAGACAACAGGAAGACCGC</p></td><td rowspan="2"><p>796 bp</p></td><td rowspan="2"><p>54 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR15">15</xref>]</p></td></tr><tr><td><p>ATCGCATCACAAGCACCAATC</p></td></tr><tr><td rowspan="2"><p><italic>aac(6′)-Ie-aph(2″)-Ia</italic></p></td><td><p>CAGGAATTTATCGAAAATGGTAGAAAAG</p></td><td rowspan="2"><p>369 bp</p></td><td rowspan="2"><p>55 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR16">16</xref>]</p></td></tr><tr><td><p>CACAATCGACTAAAGAGTACCAATC</p></td></tr><tr><td rowspan="2"><p><italic>aph(3′)-IIIa</italic></p></td><td><p>GGCTAAAATGAGAATATCACCGG</p></td><td rowspan="2"><p>523 bp</p></td><td rowspan="2"><p>55 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR16">16</xref>]</p></td></tr><tr><td><p>CTTTAAAAAATCATACAGCTCGCG</p></td></tr><tr><td rowspan="2"><p><italic>ant(4′)-Ia</italic></p></td><td><p>CAAACTGCTAAATCGGTAGAAGCC</p></td><td rowspan="2"><p>294 bp</p></td><td rowspan="2"><p>55 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR16">16</xref>]</p></td></tr><tr><td><p>GGAAAGTTGACCAGACATTACGAACT</p></td></tr><tr><td rowspan="2"><p><italic>aph(2″)-Ic</italic></p></td><td><p>CCACAATGATAATGACTCAGTTCCC</p></td><td rowspan="2"><p>444 bp</p></td><td rowspan="2"><p>55 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR16">16</xref>]</p></td></tr><tr><td><p>CCACAGCTTCCGATAGCAAGAG</p></td></tr><tr><td rowspan="2"><p><italic>aph(2″)-Ib</italic></p></td><td><p>CTTGGACGCTGAGATATATGAGCAC</p></td><td rowspan="2"><p>867 bp</p></td><td rowspan="2"><p>55 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR16">16</xref>]</p></td></tr><tr><td><p>GTTTGTAGCAATTCAGAAACACCCTT</p></td></tr><tr><td rowspan="2"><p><italic>aph(2″)-Id</italic></p></td><td><p>GTGGTTTTTACAGGAATGCCATC</p></td><td rowspan="2"><p>641 bp</p></td><td rowspan="2"><p>55 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR16">16</xref>]</p></td></tr><tr><td><p>CCCTCTTCATACCAATCCATATAACC</p></td></tr><tr><td rowspan="2"><p><italic>ant(3″)-III</italic></p></td><td><p>TGATTTGCTGGTTACGGTGAC</p></td><td rowspan="2"><p>284 bp</p></td><td rowspan="2"><p>55 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR17">17</xref>]</p></td></tr><tr><td><p>CGCTATGTTCTCTTGCTTTTG</p></td></tr><tr><td rowspan="2"><p><italic>ant(6′)-Ia</italic></p></td><td><p>ACTGGCTTAATCAATTTGGG</p></td><td rowspan="2"><p>596 bp</p></td><td rowspan="2"><p>55 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR17">17</xref>]</p></td></tr><tr><td><p>GCCTTTCCGCCACCTCACCG</p></td></tr><tr><td rowspan="2"><p><italic>PAI</italic></p></td><td><p>GACGCTCCCTTCTTTTGAC</p></td><td rowspan="2"><p>387 bp</p></td><td rowspan="2"><p>54 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR18">18</xref>]</p></td></tr><tr><td><p>CCAGAGAAATTACTACCAT</p></td></tr><tr><td rowspan="2"><p><italic>sprE</italic></p></td><td><p>GGTAAACCAACCAAGTGAATC</p></td><td rowspan="2"><p>300 bp</p></td><td rowspan="2"><p>56 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR18">18</xref>]</p></td></tr><tr><td><p>TTCTTCCGATTGACGCAAAA</p></td></tr><tr><td rowspan="2"><p><italic>ace</italic></p></td><td><p>CAGGCCAACATCAAGCAACA</p></td><td rowspan="2"><p>125 bp</p></td><td rowspan="2"><p>58 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR18">18</xref>]</p></td></tr><tr><td><p>GCTTGCCTCGCCTTCTACAA</p></td></tr><tr><td rowspan="2"><p><italic>gelE</italic></p></td><td><p>CGAAGTTGGAAAAGGAGGC</p></td><td rowspan="2"><p>372 bp</p></td><td rowspan="2"><p>54 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR18">18</xref>]</p></td></tr><tr><td><p>GGTGAAGAAGTTACTCTGA</p></td></tr><tr><td rowspan="2"><p><italic>hyl</italic></p></td><td><p>ACAGAAGAGCTGCAGGAAATG</p></td><td rowspan="2"><p>276 bp</p></td><td rowspan="2"><p>55 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR19">19</xref>]</p></td></tr><tr><td><p>GACTGACGTCCAAGTTTCCAA</p></td></tr><tr><td rowspan="2"><p><italic>cylA</italic></p></td><td><p>ACTCGGGGATTGATAGGC</p></td><td rowspan="2"><p>688 bp</p></td><td rowspan="2"><p>56 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR19">19</xref>]</p></td></tr><tr><td><p>GCTGCTAAAGCTGCGCTT</p></td></tr><tr><td rowspan="2"><p><italic>esp</italic></p></td><td><p>TTTGGGGCAACTGGAATAGT</p></td><td rowspan="2"><p>407 bp</p></td><td rowspan="2"><p>56 °C</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR18">18</xref>]</p></td></tr><tr><td><p>CCCAGCAAATAGTCCATCAT</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec4"><title>Antimicrobial susceptibility testing</title><p id="Par21">Susceptibility testing to vancomycin (30 μg), ampicillin (10 μg), tetracycline (30 μg), linezolid (30 μg), gentamicin (120 μg), chloramphenicol (30 μg), fosfomycin (200 μg), quinupristin-dalfopristin (15 μg), streptomycin (300 μg) and ciprofloxacin (5 μg) (MAST, Merseyside, U.K) was assessed according to the Clinical and Laboratory Standards Institute guidelines (CLSI) [<xref ref-type="bibr" rid="CR20">20</xref>]. Multidrug resistance was defined as resistance to three or more different classes of antibiotics. Minimum inhibitory concentration (MIC) of vancomycin was determined using the agar dilution method according to CLSI guidelines [<xref ref-type="bibr" rid="CR20">20</xref>]. The MIC was recorded as the lowest concentration that completely inhibited growth except for a single colony or a faint haze caused by the inoculum. <italic>Enterococcus faecalis</italic> ATCC29212 was used as reference strain for susceptibility testing.</p></sec><sec id="Sec5"><title>DNA extraction</title><p id="Par22">Enterococcal DNA was extracted by suspending a loop of overnight colonies in a tube containing 100 μl TE buffer (10 mM Tris-HCl; 1 mM EDTA, pH 8.0) (Merck, Germany) and 0.5 μl lysozyme (100 mg/ml) (Sigma-Aldrich, USA), and incubated at 37 °C for 1 h. The suspensions boiled for 10 min and centrifuged at 14,000 rpm for 5 min at room temperature [<xref ref-type="bibr" rid="CR11">11</xref>]. The supernatants were collected and stored at − 20 °C as DNA template stocks. The concentration and purity of DNA samples were determined using a NanoDrop Spectrophotometer (ND-1000, Nano-Drop Technologies, Wilmington, DE) at 260 and 260/280 nm, respectively.</p></sec><sec id="Sec6"><title>Detection of resistance and virulence genes</title><p id="Par23">The presence of vancomycin resistance genes <italic>vanA, vanB, vanC,</italic> aminoglycoside resistance genes <italic>aac (6′)-Ie-aph (2“)-Ia, aph (3’)-IIIa, ant (4’)-Ia, aph (2”)-Ic, aph (2“)-Ib, aph (2”)-Id, ant (3″)-III, ant (6′)-Ia</italic> and virulence genes <italic>gelE, PAI, esp, ace, cyl, hyl</italic> and <italic>sprE</italic> was assessed using PCR method (The primers [Metabion, Germany] are shown in Table <xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR21">21</xref>–<xref ref-type="bibr" rid="CR27">27</xref>]. Polymerase chain reaction was performed using DreamTaq PCR Master Mix (Ampliqon, Denmark), which contains Taq polymerase, dNTPs, MgCl2 and the appropriate buffer. Each PCR tube contained 25 μl reaction mixture composed of 12.5 μl of the master mix, 1.5 μl of each forward and reverse primer solution (in a final concentration of 200 nM), 5 μl of DNA with concentration of 100 ng/μl and nuclease-free water to complete the final volume. Amplification was performed using the Gene Atlas 322 system (ASTEC, Japan) with initial denaturation at 94 °C, 5 min followed by 30 cycles of denaturation (94 °C, 1 min), annealing (54–58 °C, 45 s) and extension (72 °C, 1 min), with a final extension step (72 °C, 10 min). The amplified DNA was separated by submarine gel electrophoresis, stained with ethidium bromide and visualized under UV transillumination (UVITEC, UK). <italic>Enterococcus faecalis</italic> ATCC 51299 and <italic>E. faecalis</italic> MMH594 was used as the positive control strain.</p></sec><sec id="Sec7"><title>Phenotypic detection of virulence factors</title><sec id="Sec8"><title>Cytolysin activity</title><p id="Par24">Cytolysin activity was assessed on Brain Heart Infusion (BHI) Agar (Merck, Germany) supplemented with 5% horse blood. Cytolytic activity was detected after 24 h incubation at 37 °C as β-hemolysis surrounding bacterial colonies [<xref ref-type="bibr" rid="CR28">28</xref>]. All assays were performed in triplicate.</p></sec><sec id="Sec9"><title>Gelatinase activity</title><p id="Par25">Gelatinase activity was assessed using 3% gelatin medium (Merck, Germany) as described previousely [<xref ref-type="bibr" rid="CR12">12</xref>]. All assays were performed in triplicate.</p></sec><sec id="Sec10"><title>Haemagglutination assay</title><p id="Par26">Haemagglutination assay was performed according to Elsner et al. [<xref ref-type="bibr" rid="CR12">12</xref>]. Enterococcal isolates were incubated for 24 h at 37 °C on BHI Agar (Merck, Germany) supplemented with 10% sheep blood. Bacterial suspension with final concentration of 1.8 × 10<sup>9</sup> CFU/mL was prepared in phosphate-buffered saline (PBS). Then, 50 μ1 of bacterial suspension mixed gently with 50 μl of 3% human erythrocyte (collected from healthy volunteer people) suspension in PBS (pH 7.4) in 96-well U-bottom microtiter plates. Haemagglutination was recorded after rotating the plates for 5 min and then keeping them at room temperature for 30 min. All assays were performed in triplicate.</p></sec><sec id="Sec11"><title>Biofilm forming assay</title><p id="Par27">Biofilm forming capacity was determined using microtiter plate as described by Zeighami et al. [<xref ref-type="bibr" rid="CR29">29</xref>]. Biofilm formation was scored as follows:<bold>_</bold>, non-biofilm forming (A595 &lt; 1); +, weak (1 &lt; A595 ≤ 2); ++, moderate (2 &lt; A595 ≤ 3); +++, strong (A595 &gt; 3). Reported values are the mean of three measurements.</p></sec><sec id="Sec12"><title>Statistical analysis</title><p id="Par28">The data were analyzed with SPSS version 17.0 software (SPSS, Inc., Chicago, IL). A chi-square and Fisher s Exact tests were used to determine the statistical significance of the data. A <italic>P</italic> value of &lt; 0.05 was considered significant.</p></sec></sec></sec><sec id="Sec13" sec-type="results"><title>Results</title><sec id="Sec14"><title>Patient demographics</title><p id="Par29">A total of 100 enterococci were collected from urine samples of hospitalized patients with symptomatic UTI. Among the total patients, 48 (48%) patients were younger than 30 years, 36 (36%) were 30–45 years and 16 (16%) were &gt; 45 years. The sex distribution was 64 (64%) female and 36 (36%) male. Of 100 enterococci, 69 isolates were identified as <italic>E. faecalis</italic>, 10 isolates as <italic>E. faecium</italic> and 21 isolates as “other” <italic>Enterococcus</italic> species.</p></sec><sec id="Sec15"><title>Antimicrobial susceptibility</title><p id="Par30">Antibiotic resistance profile of isolates is presented in Table <xref rid="Tab2" ref-type="table">2</xref>. Overall, 93 isolates were resistant to one or more antimicrobial agents, with the most frequent resistance found against tetracycline (86%), ciprofloxacin (73%) and quinupristin-dalfopristin (53%). Gentamicin and streptomycin resistance was detected in 50 and 34% of isolates, respectively. Fosfomycin showed the highest activity against isolates and only one isolate was fosfomycin resistant. Furthermore, 95% of isolates were susceptible to linezolid.
<table-wrap id="Tab2"><label>Table 2</label><caption xml:lang="en"><p>Antimicrobial resistance of <italic>Enterococcus</italic> species</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Antimicrobial agents</p></th><th><p>No. (%) ofresistant<italic>E. faecalis</italic>(<italic>n</italic> = 69)</p></th><th><p>No. (%) ofresistant<italic>E. faecium</italic>(<italic>n</italic> = 10)</p></th><th><p>No. (%) ofresistant otherEnterococcalspp. (<italic>n</italic> = 21)</p></th><th><p>No. (%) oftotalresistantisolates(<italic>n</italic> = 100)</p></th></tr></thead><tbody><tr><td><p>Vancomycin</p></td><td><p>0 (0)</p></td><td><p>7 (70)</p></td><td><p>14 (66.6)</p></td><td><p>21 (21)</p></td></tr><tr><td><p>Ampicillin</p></td><td><p>0 (0)</p></td><td><p>10 (100)</p></td><td><p>12 (57.1)</p></td><td><p>22 (22)</p></td></tr><tr><td><p>Tetracycline</p></td><td><p>62 (89.8)</p></td><td><p>9 (90)</p></td><td><p>15 (71.4)</p></td><td><p>86 (86)</p></td></tr><tr><td><p>Gentamicin</p></td><td><p>31 (45)</p></td><td><p>7 (70)</p></td><td><p>12 (57.1)</p></td><td><p>50 (50)</p></td></tr><tr><td><p>Linezolid</p></td><td><p>4 (5.8)</p></td><td><p>0</p></td><td><p>1 (4.76)</p></td><td><p>5 (5)</p></td></tr><tr><td><p>Ciprofloxacin</p></td><td><p>47 (68.1)</p></td><td><p>9 (90)</p></td><td><p>17 (80.9)</p></td><td><p>73 (73)</p></td></tr><tr><td><p>Chloramphenicol</p></td><td><p>16 (23.2)</p></td><td><p>2 (20)</p></td><td><p>3 (14.3)</p></td><td><p>21 (21)</p></td></tr><tr><td><p>Fosfomycin</p></td><td><p>1 (1.44)</p></td><td><p>0 (0)</p></td><td><p>0 (0)</p></td><td><p>1 (1)</p></td></tr><tr><td><p>Quinupristin-Dalfopristin</p></td><td><p>34 (34.8)</p></td><td><p>6 (60)</p></td><td><p>13 (61.9)</p></td><td><p>53 (53)</p></td></tr><tr><td><p>Streptomycin</p></td><td><p>19 (27.5)</p></td><td><p>5 (50)</p></td><td><p>10 (47.6)</p></td><td><p>34 (34)</p></td></tr></tbody></table></table-wrap></p><p id="Par31">Twenty one isolates were resistant to vancomycin, with MICs≥32 μg/ml, and 15% of isolates showed MIC of vancomycin ≥256 μg/ml and considered as high level vancomycin resistant (HLVR) [<xref ref-type="bibr" rid="CR30">30</xref>]. Of 21 vancomycin resistant enterococci, 10 isolates were identified as <italic>E. faecium</italic> and 11 isolates as “other” <italic>Enterococcus</italic> species. No ampicillin or vancomycin resistant <italic>E. faecalis</italic> isolate was detected.</p><p id="Par32">A total of 36 isolates were resistant to at least three different classes of antimicrobial agents and considered as MDR. The most prevalent MDR pattern was resistance to tetracycline, ciprofloxacin, gentamicin and quinupristin-dalfopristin.</p></sec><sec id="Sec16"><title>Distribution of vancomycin and aminoglycoside resistance genes</title><p id="Par33">Among 21 VRE isolates, 12 (57.1%) isolates were positive for the presence of <italic>van</italic> genes. Ten <italic>E. faecium</italic> (47.6%) isolates carried <italic>vanA</italic> and 2 (9.5%) <italic>Enterococcus</italic> species carried <italic>vanC.</italic></p><p id="Par34">The distribution of aminoglycoside resistance genes (ARGs) is presented in Table <xref rid="Tab3" ref-type="table">3</xref>. The most prevalent ARG was <italic>ant (3“)-III</italic> (78%), followed by <italic>aph (3’)-IIIa</italic> (67%), <italic>ant (6’)Ia</italic> (62%) and <italic>aac (6’)-Ie-aph (2”)-Ia</italic> (15%). The frequency of <italic>aph (2″)-Ib</italic> and <italic>ant (4′)-Ia</italic> was 7 and 4%, respectively. Frequency of ARGs in <italic>E. faecium</italic> and <italic>E. faecalis</italic> isolates did not show significant difference.
<table-wrap id="Tab3"><label>Table 3</label><caption xml:lang="en"><p>Frequency of vancomycin and aminoglycoside resistance genes in <italic>Enterococcus</italic> species</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Genes</p></th><th><p>No. (%) of <italic>E. faecalis (n</italic> = 69)</p></th><th><p>No. (%) of <italic>E. faecium (n</italic> = 10)</p></th><th><p>No. (%) of Other species (<italic>n</italic> = 21)</p></th><th><p>No. (%) of Total(<italic>n</italic> = 100)</p></th></tr></thead><tbody><tr><td><p><italic>aac(6′)-Ie-aph(2″)-Ia</italic></p></td><td><p>10 (14.5)</p></td><td><p>1 (10)</p></td><td><p>4 (19)</p></td><td><p>15 (15)</p></td></tr><tr><td><p><italic>aph(3′)-IIIa</italic></p></td><td><p>46 (66.6)</p></td><td><p>7 (70)</p></td><td><p>14 (66.7)</p></td><td><p>67 (67)</p></td></tr><tr><td><p><italic>ant(4′)-Ia</italic></p></td><td><p>3 (4.3)</p></td><td><p>0 (0)</p></td><td><p>1 (4.7)</p></td><td><p>4 (4)</p></td></tr><tr><td><p><italic>aph(2″)-Ic</italic></p></td><td><p>6 (8.7)</p></td><td><p>0 (0)</p></td><td><p>2 (9.5)</p></td><td><p>8 (8)</p></td></tr><tr><td><p><italic>aph(2″)-Ib</italic></p></td><td><p>4 (5.8)</p></td><td><p>2 (20)</p></td><td><p>1 (4.7)</p></td><td><p>7 (7)</p></td></tr><tr><td><p><italic>aph(2″)-Id</italic></p></td><td><p>5 (7.2)</p></td><td><p>2 (20)</p></td><td><p>1 (4.7)</p></td><td><p>8 (8)</p></td></tr><tr><td><p><italic>ant(3″)-III</italic></p></td><td><p>50 (72.5)</p></td><td><p>9 (90)</p></td><td><p>19 (90.5)</p></td><td><p>78 (78)</p></td></tr><tr><td><p><italic>ant(6′)-Ia</italic></p></td><td><p>41 (59.4)</p></td><td><p>6 (60)</p></td><td><p>15 (71.4)</p></td><td><p>62 (62)</p></td></tr><tr><td><p><italic>vanA</italic></p></td><td><p>0</p></td><td><p>10 (100)</p></td><td><p>0</p></td><td><p>10 (10)</p></td></tr><tr><td><p><italic>vanB</italic></p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td><p><italic>vanC</italic></p></td><td><p>0</p></td><td><p>0</p></td><td><p>2 (9.5)</p></td><td><p>2 (2)</p></td></tr></tbody></table></table-wrap></p><p id="Par35">The presence of multiple ARGs with different combinations was found in enterococci. Eighty percent of <italic>E. faecium</italic> and 78.3% of <italic>E. faecalis</italic> isolates were carried two or more ARGs (Table <xref rid="Tab4" ref-type="table">4</xref>). The number of ARGs per isolate and their specific combinations are shown in Table <xref rid="Tab4" ref-type="table">4</xref>. The most frequent combinations of ARGs in enterococci were <italic>ant (6′)Ia + ant (3′)-IIIa + aph (3′)-IIIa</italic> (15.2%), followed by <italic>aph (3′)-IIIa + ant (3′)-III</italic> (12.6%) and <italic>ant (6′)Ia + aph (3′)-IIIa</italic> (10.1%).
<table-wrap id="Tab4"><label>Table 4</label><caption xml:lang="en"><p>Frequency of different combinations of ARG among <italic>Enterococcus species</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>No. of ARG</p></th><th><p>ARG combinations</p></th><th><p>No. (%) of ARGs in <italic>E. faecalis</italic> (<italic>n</italic> = 69)</p></th><th><p>No. (%) of ARGs in <italic>E. faecium</italic> (<italic>n</italic> = 10)</p></th><th><p>Total No. (%) (<italic>n</italic> = 79)</p></th></tr></thead><tbody><tr><td><p>Without ARG</p></td><td><p>–</p></td><td><p>1 (1.4)</p></td><td><p>–</p></td><td char="(" align="char"><p>1 (1.2)</p></td></tr><tr><td rowspan="3"><p>1 ARG</p></td><td><p><italic>ant(6′)Ia</italic></p></td><td><p>5 (7.2)</p></td><td><p>–</p></td><td char="(" align="char" rowspan="3"><p>16 (20.2)</p></td></tr><tr><td><p><italic>ant(3′)-IIIa</italic></p></td><td><p>7 (10.1)</p></td><td><p>2 (20)</p></td></tr><tr><td><p><italic>aph(3′)-IIIa</italic></p></td><td><p>2 (2.8)</p></td><td><p>–</p></td></tr><tr><td rowspan="6"><p>2 ARGs</p></td><td><p><italic>aph(3′)-IIIa + ant(3′)-III</italic></p></td><td><p>8 (11.5)</p></td><td><p>2 (20)</p></td><td char="(" align="char" rowspan="6"><p>26 (32.9)</p></td></tr><tr><td><p><italic>ant(6′)Ia + ant(3′)-IIIa</italic></p></td><td><p>4 (5.7)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(6′)Ia + aph(3′)-IIIa</italic></p></td><td><p>8 (11.5)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(3′)-IIIa + aac (6′)-Ie</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(3′)-IIIa + aph(3′)-IIIa</italic></p></td><td><p>2 (2.8)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(6′)Ia + aac (6′)-Ie</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td rowspan="10"><p>3 ARGs</p></td><td><p><italic>ant(3′)-IIIa + aph(2″)-Ic + ant(4′)Ia</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td><td char="(" align="char" rowspan="10"><p>22 (27.8)</p></td></tr><tr><td><p><italic>ant(6′)Ia + ant(3′)-IIIa + aph(3′)-IIIa</italic></p></td><td><p>10 (14.4)</p></td><td><p>2 (20)</p></td></tr><tr><td><p><italic>ant(6′)Ia + aph(3′)-IIIa + aph(2″)-Ic</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(3′)-IIIa + aph(3′)-IIIa + ant(4′)Ia</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(3′)-IIIa + aph(3′)-IIIa + aph(2″)-Ic</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(3′)-IIIa + aph(3′)-IIIa + aac (6′)-Ie</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(6′)Ia + aac (6′)-Ie + aph(2″)-Ic</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(6′)Ia + ant(3′)-IIIa + aph(2″)-lb</italic></p></td><td><p>1 (1.4)</p></td><td><p>1 (10)</p></td></tr><tr><td><p><italic>ant(6′)Ia + aph(3′)-IIIa + aac (6′)-Ie</italic></p></td><td><p>–</p></td><td><p>1 (10)</p></td></tr><tr><td><p><italic>ant(3′)-IIIa + aph(2″)-ld + aph(3′)-IIIa</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td rowspan="7"><p>4 ARGs</p></td><td><p><italic>ant(6′)Ia + ant(3′)-IIIa + aph(2″)-ld + aph(3′)-IIIa</italic></p></td><td><p>2 (2.8)</p></td><td><p>1 (10)</p></td><td char="(" align="char" rowspan="7"><p>12 (15.1)</p></td></tr><tr><td><p><italic>ant(6′)Ia + ant(3′)-IIIa + aph(3′)-IIIa + aac (6′)-Ie</italic></p></td><td><p>4 (5.7)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(6′)Ia + ant(3′)-IIIa + aph(2″)-lb + aph(3′)-IIIa</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(3′)-IIIa + aph(2″)-ld + aph(3′)-IIIa + aph(2″)-Ic</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(6′)Ia + ant(3′)-IIIa + aph(2″)-ld + aac (6′)-Ie</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(6′)Ia + ant(3′)-IIIa + aph(3′)-IIIa + aph(2″)-Ic</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ant(3′)-IIIa + aph(2″)-lb + aph(3′)-IIIa + ant(4′)Ia</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td rowspan="2"><p>5 ARGs</p></td><td><p><italic>ant(6′)Ia + ant(3′)-IIIa + aph(2″)-lb + aph(3′)-IIIa + aac (6′)-Ie</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td><td char="(" align="char" rowspan="2"><p>2 (2.5)</p></td></tr><tr><td><p><italic>ant(6′)Ia + ant(3′)-IIIa + aph(2″)-lb + aph(2″)-ld + aph(3′)-IIIa</italic></p></td><td><p><bold>–</bold></p></td><td><p>1 (10)</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec17"><title>Distribution of enterococcal virulence related genes</title><p id="Par36">The virulence related genes <italic>PAI, sprE, ace, gelE, hyl, cylA</italic> and <italic>espE</italic> were detected in <italic>E. faecalis</italic> and <italic>E. faecium</italic> isolates<italic>.</italic> The frequency of enterococcal virulence genes is shown in Table <xref rid="Tab5" ref-type="table">5</xref>. The most frequent virulence gene was <italic>ace</italic> (88.6%), followed by <italic>esp</italic> (67.1%), <italic>PAI</italic> (45.5%) and <italic>sprE</italic> (41.7%). As shown in Table <xref rid="Tab5" ref-type="table">5</xref>, the frequency of <italic>ace, cylA</italic> and <italic>esp</italic> genes among <italic>E. faecalis</italic> isolates was significantly higher than <italic>E. faecium</italic> (<italic>P</italic> &lt; 0.05). All <italic>E. faecalis</italic> isolates carried at least one virulence gene. However, <italic>gelE</italic>, and <italic>cylA</italic> genes were not detected in <italic>E. faecium</italic> isolates.
<table-wrap id="Tab5"><label>Table 5</label><caption xml:lang="en"><p>Frequency of virulence genes among <italic>Enterococcus species</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>virulencegenes</p></th><th><p><italic>E. faecalis</italic>(<italic>n</italic> = 69)</p></th><th><p><italic>E. faecium</italic>(<italic>n</italic> = 10)</p></th><th><p><italic>P</italic> value</p></th><th><p>Total(<italic>n</italic> = 79)</p></th></tr></thead><tbody><tr><td><p><italic>PAI</italic></p></td><td><p>31 (44.9)</p></td><td><p>5 (50)</p></td><td><p>0.488</p></td><td><p>36 (45.5)</p></td></tr><tr><td><p><italic>sprE</italic></p></td><td><p>30 (43.4)</p></td><td><p>3 (30)</p></td><td><p>0.142</p></td><td><p>33 (41.7)</p></td></tr><tr><td><p><italic>ace</italic></p></td><td><p>62 (89.8)</p></td><td><p>8 (80)</p></td><td><p>0.001*</p></td><td><p>70 (88.6)</p></td></tr><tr><td><p><italic>gelE</italic></p></td><td><p>17 (24.6)</p></td><td><p>0</p></td><td><p>0.063</p></td><td><p>17 (21.5)</p></td></tr><tr><td><p><italic>hyl</italic></p></td><td><p>2 (2.8)</p></td><td><p>1 (10)</p></td><td><p>0.337</p></td><td><p>3 (3.8)</p></td></tr><tr><td><p><italic>cylA</italic></p></td><td><p>25 (36.2)</p></td><td><p>0</p></td><td><p>0.017*</p></td><td><p>25 (31.6)</p></td></tr><tr><td><p><italic>esp</italic></p></td><td><p>50 (72.4)</p></td><td><p>3 (30)</p></td><td><p>0.012*</p></td><td><p>53 (67.1)</p></td></tr></tbody></table><table-wrap-foot><p>Fisher s Exact test was used to determine the statistical significance of the data</p><p>*<italic>P</italic> value of &lt; 0.05 was considered significant</p></table-wrap-foot></table-wrap></p><p id="Par37">Several different combinations of virulence genes were found in enterococci. Table <xref rid="Tab6" ref-type="table">6</xref> shows that 97.1% of <italic>E. faecalis</italic> and 50% of <italic>E. faecium</italic> isolates harbored two or more virulence genes simultaneously (<italic>P</italic> &lt; 0.05). The mean number of virulence genes per isolate was higher in <italic>E. faecalis</italic> isolates than <italic>E. faecium</italic> (<italic>P</italic> &lt; 0.05). The most frequent combination in <italic>E. faecalis</italic> was <italic>PAI-sprE-ace-esp</italic> (13%), followed by<italic>PAI-ace-cylA-esp</italic> and <italic>ace-cylA-esp</italic> (8.6%).
<table-wrap id="Tab6"><label>Table 6</label><caption xml:lang="en"><p>Frequency of different combinations of virulence genes among <italic>Enterococcus species</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Genetic profile</p></th><th><p>No. (%) of <italic>E. faecalis</italic>(<italic>n</italic> = 69)</p></th><th><p>No. (%) of <italic>E. faecium</italic>(<italic>n</italic> = 10)</p></th></tr></thead><tbody><tr><td><p>No virulence factor</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p><italic>PAI</italic></p></td><td><p>–</p></td><td><p>1 (10)</p></td></tr><tr><td><p><italic>Ace</italic></p></td><td><p>2 (2.8)</p></td><td><p>4 (40)</p></td></tr><tr><td><p><italic>PAI-ace</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>sprE-ace</italic></p></td><td><p>2 (2.8)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ace-gelE</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ace-hyl</italic></p></td><td><p>1 (1.4)</p></td><td><p>1 (10)</p></td></tr><tr><td><p><italic>PAI-esp</italic></p></td><td><p>1 (1.4)</p></td><td><p>1 (10)</p></td></tr><tr><td><p><italic>ace-esp</italic></p></td><td><p>4 (5.7)</p></td><td><p>–</p></td></tr><tr><td><p><italic>gelE-esp</italic></p></td><td><p>2 (2.8)</p></td><td><p>–</p></td></tr><tr><td><p><italic>cylA-esp</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>PAI-sprE-ace</italic></p></td><td><p>4 (5.7)</p></td><td><p>1 (10)</p></td></tr><tr><td><p><italic>sprE-ace-gelE</italic></p></td><td><p>3 (4.3)</p></td><td><p>–</p></td></tr><tr><td><p><italic>PAI-ace-cylA</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ace-gelE-cylA</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ace-hyl-cylA</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>PAI-sprE-esp</italic></p></td><td><p>2 (2.8)</p></td><td><p>–</p></td></tr><tr><td><p><italic>PAI-ace-esp</italic></p></td><td><p>5 (7.2)</p></td><td><p>–</p></td></tr><tr><td><p><italic>sprE-ace-esp</italic></p></td><td><p>4 (5.7)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ace-gelE-esp</italic></p></td><td><p>2 (2.8)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ace-cylA-esp</italic></p></td><td><p>6 (8.6)</p></td><td><p>–</p></td></tr><tr><td><p><italic>sprE-ace-gelE-cylA</italic></p></td><td><p>2 (2.8)</p></td><td><p>–</p></td></tr><tr><td><p><italic>PAI-sprE-ace-esp</italic></p></td><td><p>9 (13)</p></td><td><p>2 (20)</p></td></tr><tr><td><p><italic>sprE-ace-gelE-esp</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>PAI-ace-cylA-esp</italic></p></td><td><p>6 (8.6)</p></td><td><p>–</p></td></tr><tr><td><p><italic>sprE-gelE-cylA-esp</italic></p></td><td><p>1 (1.4)</p></td><td><p>–</p></td></tr><tr><td><p><italic>ace-gelE-cylA-esp</italic></p></td><td><p>4 (5.7)</p></td><td><p>–</p></td></tr><tr><td><p><italic>PAI-sprE-ace-cylA-esp</italic></p></td><td><p>2 (2.8)</p></td><td><p>–</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec18"><title>Phenotypic detection of virulence factors</title><p id="Par38">Gelatinase and cytolytic activity, haemagglutination and biofilm formation was assayed by phenotypic tests (Table <xref rid="Tab7" ref-type="table">7</xref>). Hemolytic activity of <italic>E. faecalis</italic> isolates (46.4%) was higher than other <italic>Enterococcus</italic> spp. (14.3%). Hemolytic activity cannot be detected in <italic>E. faecium</italic> isolates. Gelatinase activity was detected in 25% of enterococci. However, there was no significant difference among <italic>Enterococcus</italic> species in gelatinase activity (<italic>P</italic> &gt; 0.05). Haemagglutination and biofilm formation phenotypes were detected in 75 and 74% of enterococci. Biofilm formation in <italic>E. faecalis</italic> isolates (89.8%) was significantly higher than other species. Of 74 biofilm forming isolates, 64 isolates produced weak biofilm (+) and 10 isolates formed moderate biofilm (++). Frequency of resistance genes among virulence factors producing entrococci is shown in Table <xref rid="Tab8" ref-type="table">8</xref>. The resistance genes of <italic>aph (3′)-IIIa</italic>, <italic>ant (3′)-III</italic> and <italic>ant (6′)Ia</italic> were detected significantly higher among enterococci with haemagglutination and biofilm formation phenotypes (<italic>P</italic> &lt; 0.05). Also, all resistance genes (except <italic>vanC, ant (4′)Ia</italic> and <italic>aph (3′)-IIIa</italic>) were frequently detected in isolates with gelatinase and cytolytic activity (P &lt; 0.05).
<table-wrap id="Tab7"><label>Table 7</label><caption xml:lang="en"><p>Phenotypic detection of virulence factors in <italic>Enterococcus species</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Virulencefactors</p></th><th><p><italic>E. faecalis</italic> (<italic>n</italic> = 69) No. (%)</p></th><th><p><italic>E. faecium</italic> (<italic>n</italic> = 10) No. (%)</p></th><th><p>Other <italic>spp</italic>.(<italic>n</italic> = 21)No. (%)</p></th><th><p><italic>P</italic> value</p></th><th><p>Total(<italic>n</italic> = 100)No. (%)</p></th></tr></thead><tbody><tr><td><p>Cytolytic activity</p></td><td><p>32 (46.4)</p></td><td><p>0</p></td><td><p>3 (14.3)</p></td><td><p>0.001*</p></td><td><p>35 (35)</p></td></tr><tr><td><p>Gelatinase activity</p></td><td><p>18 (26.1)</p></td><td><p>0</p></td><td><p>7 (33.3)</p></td><td><p>0.107</p></td><td><p>25 (25)</p></td></tr><tr><td><p>Hemagglutination</p></td><td><p>55 (79.7)</p></td><td><p>7 (70)</p></td><td><p>13 (61.9)</p></td><td><p>0.245</p></td><td><p>75 (75)</p></td></tr><tr><td><p>Biofilm formation</p></td><td><p>62 (89.8)</p></td><td><p>2 (20)</p></td><td><p>10 (47.6)</p></td><td><p>0.000*</p></td><td><p>74 (74)</p></td></tr></tbody></table><table-wrap-foot><p>Fisher s Exact test was used to determine the statistical significance of the data</p><p>*<italic>P</italic> value of &lt; 0.05 was considered significant</p></table-wrap-foot></table-wrap><table-wrap id="Tab8"><label>Table 8</label><caption xml:lang="en"><p>Frequency of resistance genes among virulence factors producing entrococci</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Resistance genes</p></th><th rowspan="2"><p>Van A(<italic>n</italic> = 10)</p></th><th rowspan="2"><p>Van C (<italic>n</italic> = 2)</p></th><th rowspan="2"><p><italic>aac(6′)-Ie-aph(2″)-Ia (n = 20)</italic></p></th><th rowspan="2"><p><italic>aph(3′)-IIIa (n = 71)</italic></p></th><th rowspan="2"><p><italic>ant(4′)-Ia (n = 6)</italic></p></th><th rowspan="2"><p><italic>aph(2″)-Ic (n = 9)</italic></p></th><th rowspan="2"><p><italic>aph(2″)-Ib (n = 5)</italic></p></th><th rowspan="2"><p><italic>aph(2″)-Id (n = 7)</italic></p></th><th rowspan="2"><p><italic>ant(3″)-III (n = 84)</italic></p></th><th rowspan="2"><p><italic>ant(6′)-Ia (n = 57)</italic></p></th></tr><tr><th><p>Virulence factors</p></th></tr></thead><tbody><tr><td><p>Cytolytic activity (<italic>n</italic> = 35)</p></td><td><p>8*</p></td><td><p>1</p></td><td><p>14*</p></td><td><p>20*</p></td><td><p>4</p></td><td><p>8*</p></td><td><p>4*</p></td><td><p>6*</p></td><td><p>34*</p></td><td><p>32*</p></td></tr><tr><td><p>Gelatinase activity (<italic>n</italic> = 25)</p></td><td><p>8*</p></td><td><p>2</p></td><td><p>18*</p></td><td><p>16</p></td><td><p>6*</p></td><td><p>9*</p></td><td><p>4*</p></td><td><p>7*</p></td><td><p>25*</p></td><td><p>25*</p></td></tr><tr><td><p>Hemagglutination (<italic>n</italic> = 75)</p></td><td><p>7</p></td><td><p>1</p></td><td><p>13</p></td><td><p>60*</p></td><td><p>5</p></td><td><p>9</p></td><td><p>5</p></td><td><p>7</p></td><td><p>74*</p></td><td><p>53*</p></td></tr><tr><td><p>Biofilm formation (<italic>n</italic> = 74)</p></td><td><p>10</p></td><td><p>1</p></td><td><p>17</p></td><td><p>66*</p></td><td><p>6</p></td><td><p>8</p></td><td><p>5</p></td><td><p>7</p></td><td><p>74*</p></td><td><p>56*</p></td></tr></tbody></table><table-wrap-foot><p>Fisher s Exact test was used to determine the statistical significance of the data</p><p>*<italic>P</italic> value of &lt; 0.05 was considered significant</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec19" sec-type="discussion"><title>Discussion</title><p id="Par39">Multidrug resistant enterococci, as important nosocomial pathogens, have become a serious problem in hospitalized patients [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Due to the extensive misuse of antimicrobial agents in our country, treatment of infections associated with MDR enterococci is complicated [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. In our study, 93% of enterococci were resistant to one or more antimicrobial agents and 36% were MDR. The frequency of antimicrobial resistance among <italic>E. faecium</italic> isolates was more than <italic>E. faecalis</italic> (except for linezolid and fosfomycin). The inherent antibiotic resistance and dissemination of resistance genes through conjugative transposons and plasmids play an important role in development of MDR enterococci [<xref ref-type="bibr" rid="CR33">33</xref>]. High frequency of antimicrobial resistance among enterococci was reported in previous studies from Iran [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR34">34</xref>].</p><p id="Par40">While intrinsic mechanisms result in low level aminoglycoside resistance, acquisition of mobile genetic elements typically underlies high level aminoglycoside resistance in <italic>E. faecium</italic> and <italic>E. faecalis</italic> [<xref ref-type="bibr" rid="CR4">4</xref>]. High level aminoglycoside resistance among enterococci was first reported in France in 1979 and since then has caused serious problems in healthcare settings worldwide [<xref ref-type="bibr" rid="CR6">6</xref>]. Recent studies indicated that HLGR among enterococci to be more common than HLSR [<xref ref-type="bibr" rid="CR35">35</xref>]. Similarly, gentamycin resistant enterococci (50%) were detected with higher frequency than streptomycin resistance (34%) in our study. Also, Mirnejad et al. and Zarrilli et al. were reported that 56.9 and 46.1% of enterococci were HLGR, respectively [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par41">Aminoglycoside resistance genes in <italic>E. faecium</italic> isolates were detected with higher frequency than <italic>E. faecalis,</italic> an observation which is consistent with that found in previous reports [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. While previous studies found that <italic>aac (6′)-Ie-aph (2″)-Ia</italic> was the most common ARG [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], we detected <italic>aac (6′)-Ie-aph (2″)-Ia</italic> with lower frequency in 15% of enterococci. According to our results, the most prevalent ARG was <italic>ant (3″)-III</italic> (78%), followed by <italic>aph (3′)-IIIa</italic> (67%), <italic>ant (6′)Ia</italic> (62%).</p><p id="Par42">Furthermore, 80 % of <italic>E. faecium</italic> and 78.3% of <italic>E. faecalis</italic> isolates were carried two or more ARGs. Our results are consistent with previous reports on the predominance of enterococci with two or more ARGs [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR35">35</xref>] .</p><p id="Par43">High level vancomycin resistance, leading causes of hospital-acquired infections, were first reported in United Kingdom in 1980s and since then have caused significant public health concern because of its propensity to acquire and transfer the mobile resistance genes [<xref ref-type="bibr" rid="CR14">14</xref>]. As reported in previous studies, the most common risk factors for VRE infections are prolonged hospitalization, use of vancomycin and third-generation cephalosporins and chronic dialysis [<xref ref-type="bibr" rid="CR15">15</xref>]. In our study, 15% of enterococci were high level vancomycin-resistant with MIC of ≥256 μg/ml and 21% were vancomycin resistant which consistent with some previous reports [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. No vancomycin resistant <italic>E. faecalis</italic> (VRE<sub><italic>fs</italic></sub>) was found in our study. In contrast to our results, the frequency of VRE<sub><italic>fs</italic></sub> was higher than vancomycin resistant <italic>E. faecium</italic> (VRE<sub><italic>fm</italic></sub>) in study carried out by Sabouni et al. in Iran [<xref ref-type="bibr" rid="CR16">16</xref>]. Similar to our study, Wisplinghoff et al. reported vancomycin resistance in 2% of <italic>E. faecalis</italic> and 60% of <italic>E. faecium</italic> isolates. However, they did not report high level vancomycin resistance [<xref ref-type="bibr" rid="CR17">17</xref>]. National survey data have indicated the prevalence of VRE in 0–59% of isolates in 126 adult ICUs from 60 US hospitals [<xref ref-type="bibr" rid="CR18">18</xref>]. Several reports also showed the elevated occurrence of <italic>vanA</italic> in comparison to other <italic>van</italic> types [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. We found a high occurrence of <italic>vanA</italic> in VRE isolates. Several hospitals located in São Paulo and other Brazilian cities reported both outbreaks and isolated cases of VRE infection/colonization [<xref ref-type="bibr" rid="CR19">19</xref>]. All VRE<sub><italic>fm</italic></sub> isolates carried <italic>vanA</italic> but <italic>vanB</italic> was not detected among enterococci in our study. Similar to our results, Cekin et al. did not detected <italic>vanB</italic> among enterococci [<xref ref-type="bibr" rid="CR31">31</xref>].</p><p id="Par44">The essential virulence factors for pathogenicity of enterococci have not yet been described and the pathogenicity has been considered a multifactorial process [<xref ref-type="bibr" rid="CR10">10</xref>]. Previous studies showed the association between the presence of virulence factors and promoting emergence of enterococcal infections in nosocomial settings [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Our results showed different prevalence of virulence genes in enterococci which ranged from 3.9 to 8.6%. The most frequent virulence genes were <italic>ace</italic> and <italic>esp</italic>. Ace is an adhesion of collagen from <italic>Enterococcus</italic> that binds to collagen and laminin and belongs to the MSCRAMM family. In Bulgaria, Strateva et al. reported varied distribution of <italic>esp</italic> in non-invasive <italic>E. faecalis</italic> isolates (54.3–64.8%) compared to invasive isolates (33.3%) [<xref ref-type="bibr" rid="CR2">2</xref>]. In our study, <italic>ace</italic> and <italic>esp</italic> were found respectively among 88.6 and 67.1% of enterococci isolated from UTIs, which confirm the important role of Ace and Esp as colonization factors in UTIs. The frequency of <italic>ace</italic> and <italic>esp</italic> in <italic>E. faecalis</italic> isolates was significantly higher than <italic>E. faecium.</italic> A strong correlation between the presence of Esp and the ability of an <italic>Enterococcus</italic> isolate to colonizes and persists in urinary tract and forms biofilm in vitro has been reported [<xref ref-type="bibr" rid="CR10">10</xref>]. According to our results, 74% of enterococci showed biofilm formation phenotype which exhibits an important role of biofilm formation in UTIs. The virulence genes <italic>gelE</italic> and <italic>cylA</italic> were not detected in <italic>E. faecium</italic> isolates. Similar to our results, a multicenter study on distribution of virulence determinants in fecal <italic>E. faecium</italic> isolates of patients in 13 hospitals from nine European countries showed total absence of <italic>gelE</italic> gene. However, 26 and 36.2% of <italic>E. faecalis</italic> isolates carried <italic>gelE</italic> and <italic>cylA</italic> determinants, respectively. The least prevalence among enterococci was <italic>hyl</italic> which was detected in only 3 isolates (3.9%). Similar to our results, Soheili et al. demonstrated that only 8% of <italic>E. faecalis</italic> isolates in Malaysian patients carried <italic>hyl</italic> [<xref ref-type="bibr" rid="CR1">1</xref>]. Since <italic>hyl</italic> was not prevalent in our study and some previous reports [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR28">28</xref>], we believe that this gene could has little role in pathogenicity of <italic>Enterococcus</italic> in comparison with other prevalent virulence genes.</p><p id="Par45">According to our results, 97.1% of <italic>E. faecalis</italic> and 50% of <italic>E. faecium</italic> isolates harbored two or more virulence genes simultaneously (<italic>P</italic> &lt; 0.05). Furthermore, among gentamycin resistant enterococci, 45 isolates (90%) were carried at least two or more virulence genes which is consistent with previous reports [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Also, 42% of VRE isolates were harbored at least two or more virulence determinants.</p><p id="Par46">One of the limitations of our study was the low number of <italic>E. faecium</italic> isolates and since the study was conducted in small geographical area, Northwest of Iran, the results cannot be generalized. For better characterization of enterococci strains, we suggest that molecular typing methods such as pulsed-field gel electrophoresis and multilocus sequence typing will be done.</p></sec><sec id="Sec20" sec-type="conclusions"><title>Conclusion</title><p id="Par47">Our study demonstrated that <italic>E. faecalis</italic> was more common than other <italic>Enterococcus</italic> species, but high frequency of aminoglycoside and vancomycin resistance was detected among <italic>E. faecium</italic> isolates<italic>.</italic> The distribution of virulence genes (except <italic>hyl</italic>) among <italic>E. faecalis</italic> isolates was higher than <italic>E. faecium</italic>. Due to high frequency of MDR enterococci, it seems that the appropriate surveillance and control measures are essential to prevent the emergence and transmission of these isolates in hospitals. Further studies should be carried out for a better understanding of the association between the presence of virulence determinants and emergence of multidrug resistant enterococci.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors would like to acknowledge Aidin Jahanshahi for his support in sampling.</p></ack><sec sec-type="author-contribution"><title>Authors’ contributions</title><p>FH and HZ involved in the project development, data management and manuscript writing. VL participated in project development, data analysis. All authors have read and approved the final version of manuscript.</p></sec><sec><title>Funding</title><p>This work was funded as an MSc thesis in Medical Microbiology by the Zanjan University of Medical Sciences (A-12-392-17, A-12-392-14). The study was designed, conducted, analyzed, and written by the authors without involvement of any commercial party.</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>The datasets will not be available on a publically available website, but it may be possible to provide access to anonymized data. Anyone who wants to request the data can contact with Habib Zeighami, corresponding author.</p></sec><sec sec-type="ethics-statement"><sec id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par48">Ethical clearance was obtained from the Ethics Committee of Zanjan University of Medical Sceinces before conducting the study (IR.ZUMS.REC.1394.324, ZUMS.REC.1394.177). All participants provided written informed consent to participate in the studies.</p></sec><sec id="FPar2"><title>Consent for publication</title><p id="Par49">Not applicable.</p></sec><sec id="FPar3" sec-type="COI-statement"><title>Competing interests</title><p id="Par50">The authors declare that they have no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soheili</surname><given-names>S</given-names></name><name><surname>Ghafourian</surname><given-names>S</given-names></name><name><surname>Sekawi</surname><given-names>Z</given-names></name><name><surname>Neela</surname><given-names>V</given-names></name><name><surname>Sadeghifard</surname><given-names>N</given-names></name><name><surname>Ramli</surname><given-names>R</given-names></name><name><surname>Hamat</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">Wide distribution of virulence genes among Enterococcus faecium and Enterococcus faecalis clinical isolates</article-title><source>Sci World J</source><year>2014</year><volume>2014</volume><fpage>623174</fpage><pub-id pub-id-type="doi">10.1155/2014/623174</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strateva</surname><given-names>T</given-names></name><name><surname>Atanasova</surname><given-names>D</given-names></name><name><surname>Savov</surname><given-names>E</given-names></name><name><surname>Petrova</surname><given-names>G</given-names></name><name><surname>Mitov</surname><given-names>I</given-names></name></person-group><article-title xml:lang="en">Incidence of virulence determinants in clinical Enterococcus faecalis and Enterococcus faecium isolates collected in Bulgaria</article-title><source>Braz J Infect Dis</source><year>2016</year><volume>20</volume><issue>2</issue><fpage>127</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">26849965</pub-id><pub-id pub-id-type="doi">10.1016/j.bjid.2015.11.011</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharifi</surname><given-names>Y</given-names></name><name><surname>Hasani</surname><given-names>A</given-names></name><name><surname>Ghotaslou</surname><given-names>R</given-names></name><name><surname>Naghili</surname><given-names>B</given-names></name><name><surname>Aghazadeh</surname><given-names>M</given-names></name><name><surname>Milani</surname><given-names>M</given-names></name><name><surname>Bazmany</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Virulence and antimicrobial resistance in enterococci isolated from urinary tract infections</article-title><source>Adv Pharm Bull</source><year>2013</year><volume>3</volume><issue>1</issue><fpage>197</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">24312835</pub-id><pub-id pub-id-type="pmcid">3846047</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollenbeck</surname><given-names>BL</given-names></name><name><surname>Rice</surname><given-names>LB</given-names></name></person-group><article-title xml:lang="en">Intrinsic and acquired resistance mechanisms in enterococcus</article-title><source>Virulence</source><year>2012</year><volume>3</volume><issue>5</issue><fpage>421</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">23076243</pub-id><pub-id pub-id-type="pmcid">3485979</pub-id><pub-id pub-id-type="doi">10.4161/viru.21282</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasaj</surname><given-names>M</given-names></name><name><surname>Mousavi</surname><given-names>SM</given-names></name><name><surname>Hosseini</surname><given-names>SM</given-names></name><name><surname>Arabestani</surname><given-names>MR</given-names></name></person-group><article-title xml:lang="en">Prevalence of virulence factors and vancomycin-resistant genes among Enterococcus faecalis and E. faecium isolated from clinical specimens</article-title><source>Iran J Public Health</source><year>2016</year><volume>45</volume><issue>6</issue><fpage>806</fpage><lpage>813</lpage><pub-id pub-id-type="pmid">27648425</pub-id><pub-id pub-id-type="pmcid">5026837</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>Q</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Ye</surname><given-names>R</given-names></name><name><surname>Lv</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Characterization of aminoglycoside resistance and virulence genes among Enterococcus spp. isolated from a hospital in China</article-title><source>Int J Environ Res Public Health</source><year>2015</year><volume>12</volume><issue>3</issue><fpage>3014</fpage><lpage>3025</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXmtFWit7o%3D</pub-id><pub-id pub-id-type="pmid">25768240</pub-id><pub-id pub-id-type="pmcid">4377949</pub-id><pub-id pub-id-type="doi">10.3390/ijerph120303014</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebreton</surname><given-names>F</given-names></name><name><surname>Depardieu</surname><given-names>F</given-names></name><name><surname>Bourdon</surname><given-names>N</given-names></name><name><surname>Fines-Guyon</surname><given-names>M</given-names></name><name><surname>Berger</surname><given-names>P</given-names></name><name><surname>Camiade</surname><given-names>S</given-names></name><name><surname>Leclercq</surname><given-names>R</given-names></name><name><surname>Courvalin</surname><given-names>P</given-names></name><name><surname>Cattoir</surname><given-names>V</given-names></name></person-group><article-title xml:lang="en">D-ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium</article-title><source>Antimicrob Agents Chemother</source><year>2011</year><volume>55</volume><issue>10</issue><fpage>4606</fpage><lpage>4612</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXhtl2nsL7L</pub-id><pub-id pub-id-type="pmid">21807981</pub-id><pub-id pub-id-type="pmcid">3187002</pub-id><pub-id pub-id-type="doi">10.1128/AAC.00714-11</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamane</surname><given-names>K</given-names></name><name><surname>Wachino</surname><given-names>J</given-names></name><name><surname>Doi</surname><given-names>Y</given-names></name><name><surname>Kurokawa</surname><given-names>H</given-names></name><name><surname>Arakawa</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Global spread of multiple aminoglycoside resistance genes</article-title><source>Emerg Infect Dis</source><year>2005</year><volume>11</volume><issue>6</issue><fpage>951</fpage><lpage>953</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXlsFSitLw%3D</pub-id><pub-id pub-id-type="pmid">15963295</pub-id><pub-id pub-id-type="pmcid">3367594</pub-id><pub-id pub-id-type="doi">10.3201/eid1106.040924</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirnejad</surname><given-names>R</given-names></name><name><surname>Sajjadi</surname><given-names>N</given-names></name><name><surname>Masoumi Zavaryani</surname><given-names>S</given-names></name><name><surname>Piranfar</surname><given-names>V</given-names></name><name><surname>Hajihosseini</surname><given-names>M</given-names></name><name><surname>Roshanfekr</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Identification of aminoglycoside resistance genes by triplex PCR in Enterococcus spp. isolated from ICUs</article-title><source>Infez Med</source><year>2016</year><volume>24</volume><issue>3</issue><fpage>222</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">27668903</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comerlato</surname><given-names>CB</given-names></name><name><surname>Resende</surname><given-names>MC</given-names></name><name><surname>Caierao</surname><given-names>J</given-names></name><name><surname>d'Azevedo</surname><given-names>PA</given-names></name></person-group><article-title xml:lang="en">Presence of virulence factors in Enterococcus faecalis and Enterococcus faecium susceptible and resistant to vancomycin</article-title><source>Mem Inst Oswaldo Cruz</source><year>2013</year><volume>108</volume><issue>5</issue><fpage>590</fpage><lpage>595</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhs1SitrjJ</pub-id><pub-id pub-id-type="pmid">23903974</pub-id><pub-id pub-id-type="pmcid">3970601</pub-id><pub-id pub-id-type="doi">10.1590/S0074-02762013000500009</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>DM</given-names></name><name><surname>Talavera</surname><given-names>GN</given-names></name><name><surname>Hernández</surname><given-names>LA</given-names></name><name><surname>Weisberg</surname><given-names>SB</given-names></name><name><surname>Ambrose</surname><given-names>RF</given-names></name><name><surname>Jay</surname><given-names>JA</given-names></name></person-group><article-title xml:lang="en">Virulence genes among <italic>Enterococcus faecalis</italic> and <italic>Enterococcus faecium</italic> isolated from coastal beaches and human and nonhuman sources in Southern California and Puerto Rico</article-title><source>J Pathog</source><year>2016</year><volume>2016</volume><fpage>3437214</fpage><pub-id pub-id-type="pmid">27144029</pub-id><pub-id pub-id-type="pmcid">4842068</pub-id><pub-id pub-id-type="doi">10.1155/2016/3437214</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elsner</surname><given-names>HA</given-names></name><name><surname>Sobottka</surname><given-names>I</given-names></name><name><surname>Mack</surname><given-names>D</given-names></name><name><surname>Claussen</surname><given-names>M</given-names></name><name><surname>Laufs</surname><given-names>R</given-names></name><name><surname>Wirth</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2000</year><volume>19</volume><issue>1</issue><fpage>39</fpage><lpage>42</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD3c7mvVKqtw%3D%3D</pub-id><pub-id pub-id-type="pmid">10706178</pub-id><pub-id pub-id-type="doi">10.1007/s100960050007</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarrilli</surname><given-names>R</given-names></name><name><surname>Tripodi</surname><given-names>MF</given-names></name><name><surname>Di Popolo</surname><given-names>A</given-names></name><name><surname>Fortunato</surname><given-names>R</given-names></name><name><surname>Bagattini</surname><given-names>M</given-names></name><name><surname>Crispino</surname><given-names>M</given-names></name><name><surname>Florio</surname><given-names>A</given-names></name><name><surname>Triassi</surname><given-names>M</given-names></name><name><surname>Utili</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy</article-title><source>J Antimicrob Chemother</source><year>2005</year><volume>56</volume><issue>5</issue><fpage>827</fpage><lpage>835</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXhtFCjtLbE</pub-id><pub-id pub-id-type="pmid">16186168</pub-id><pub-id pub-id-type="doi">10.1093/jac/dki347</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg Goldstein</surname><given-names>RE</given-names></name><name><surname>Micallef</surname><given-names>SA</given-names></name><name><surname>Gibbs</surname><given-names>SG</given-names></name><name><surname>George</surname><given-names>A</given-names></name><name><surname>Claye</surname><given-names>E</given-names></name><name><surname>Sapkota</surname><given-names>A</given-names></name><name><surname>Joseph</surname><given-names>SW</given-names></name><name><surname>Sapkota</surname><given-names>AR</given-names></name></person-group><article-title xml:lang="en">Detection of vancomycin-resistant enterococci (VRE) at four U.S. wastewater treatment plants that provide effluent for reuse</article-title><source>Sci Total Environ</source><year>2014</year><volume>466-467</volume><fpage>404</fpage><lpage>411</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhslKrurbE</pub-id><pub-id pub-id-type="pmid">23933428</pub-id><pub-id pub-id-type="doi">10.1016/j.scitotenv.2013.07.039</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghalandarzadeh Daryaei</surname><given-names>Z</given-names></name><name><surname>Javadpour</surname><given-names>S</given-names></name><name><surname>Kargar</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Frequency of vana &amp; vanb genes in vancomycin-resistant enterococci isolated from clinical specimens at shahid mohammadi hospitals bandar abbass</article-title><source>J Microbial World</source><year>2013</year><volume>6</volume><issue>1</issue><fpage>23</fpage><lpage>33</lpage></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabouni</surname><given-names>F</given-names></name><name><surname>Movahedi</surname><given-names>Z</given-names></name><name><surname>Mahmoudi</surname><given-names>S</given-names></name><name><surname>Pourakbari</surname><given-names>B</given-names></name><name><surname>Keshavarz Valian</surname><given-names>S</given-names></name><name><surname>Mamishi</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">High frequency of vancomycin resistant <italic>Enterococcus faecalis</italic> in children: an alarming concern</article-title><source>J Prev Med Hyg</source><year>2016</year><volume>57</volume><issue>4</issue><fpage>E201</fpage><lpage>E204</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BC1c3jslOnsQ%3D%3D</pub-id><pub-id pub-id-type="pmid">28167857</pub-id><pub-id pub-id-type="pmcid">5289031</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisplinghoff</surname><given-names>H</given-names></name><name><surname>Bischoff</surname><given-names>T</given-names></name><name><surname>Tallent</surname><given-names>SM</given-names></name><name><surname>Seifert</surname><given-names>H</given-names></name><name><surname>Wenzel</surname><given-names>RP</given-names></name><name><surname>Edmond</surname><given-names>MB</given-names></name></person-group><article-title xml:lang="en">Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study</article-title><source>Clin Infect Dis</source><year>2004</year><volume>39</volume><issue>3</issue><fpage>309</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1086/421946</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fridkin</surname><given-names>SK</given-names></name><name><surname>Edwards</surname><given-names>JR</given-names></name><name><surname>Courval</surname><given-names>JM</given-names></name><name><surname>Hill</surname><given-names>H</given-names></name><name><surname>Tenover</surname><given-names>FC</given-names></name><name><surname>Lawton</surname><given-names>R</given-names></name><name><surname>Gaynes</surname><given-names>RP</given-names></name><name><surname>McGowan</surname><given-names>JE</given-names><suffix>Jr</suffix></name></person-group><article-title xml:lang="en">The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units</article-title><source>Ann Intern Med</source><year>2001</year><volume>135</volume><issue>3</issue><fpage>175</fpage><lpage>183</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3MXmtlWktr0%3D</pub-id><pub-id pub-id-type="pmid">11487484</pub-id><pub-id pub-id-type="doi">10.7326/0003-4819-135-3-200108070-00009</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maschieto</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>R</given-names></name><name><surname>Palazzo</surname><given-names>IC</given-names></name><name><surname>Darini</surname><given-names>AL</given-names></name></person-group><article-title xml:lang="en">Antimicrobial resistance of Enterococcus sp. isolated from the intestinal tract of patients from a university hospital in Brazil</article-title><source>Mem Inst Oswaldo Cruz</source><year>2004</year><volume>99</volume><issue>7</issue><fpage>763</fpage><lpage>767</lpage><pub-id pub-id-type="pmid">15654436</pub-id><pub-id pub-id-type="doi">10.1590/S0074-02762004000700018</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>M100-S27</collab></person-group><source>Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing</source><year>2017</year><edition>27</edition><fpage>94</fpage><lpage>97</lpage></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kariyama</surname><given-names>R</given-names></name><name><surname>Mitsuhata</surname><given-names>R</given-names></name><name><surname>Chow</surname><given-names>JW</given-names></name><name><surname>Clewell</surname><given-names>DB</given-names></name><name><surname>Kumon</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci</article-title><source>J Clin Microbiol</source><year>2000</year><volume>38</volume><issue>8</issue><fpage>3092</fpage><lpage>3095</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3cXlvFKgsbY%3D</pub-id><pub-id pub-id-type="pmid">10921985</pub-id><pub-id pub-id-type="pmcid">87194</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>NC</given-names></name><name><surname>Cooksey</surname><given-names>RC</given-names></name><name><surname>Hill</surname><given-names>BC</given-names></name><name><surname>Swenson</surname><given-names>JM</given-names></name><name><surname>Tenover</surname><given-names>FC</given-names></name></person-group><article-title xml:lang="en">Characterization of glycopeptide-resistant enterococci from U.S. hospitals</article-title><source>Antimicrob Agents Chemother.</source><year>1993</year><volume>37</volume><issue>11</issue><fpage>2311</fpage><lpage>2317</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK2cXislehsA%3D%3D</pub-id><pub-id pub-id-type="pmid">8285611</pub-id><pub-id pub-id-type="pmcid">192384</pub-id><pub-id pub-id-type="doi">10.1128/AAC.37.11.2311</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emaneini</surname><given-names>M</given-names></name><name><surname>Aligholi</surname><given-names>M</given-names></name><name><surname>Aminshahi</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Characterization of glycopeptides, aminoglycosides and macrolide resistance among Enterococcus faecalis and Enterococcus faecium isolates from hospitals in Tehran</article-title><source>Pol J Microbiol</source><year>2008</year><volume>57</volume><issue>2</issue><fpage>173</fpage><lpage>178</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXht1Clsr7J</pub-id><pub-id pub-id-type="pmid">18646406</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vakulenko</surname><given-names>SB</given-names></name><name><surname>Donabedian</surname><given-names>SM</given-names></name><name><surname>Voskresenskiy</surname><given-names>AM</given-names></name><name><surname>Zervos</surname><given-names>MJ</given-names></name><name><surname>Lerner</surname><given-names>SA</given-names></name><name><surname>Chow</surname><given-names>JW</given-names></name></person-group><article-title xml:lang="en">Multiplex PCR for detection of aminoglycoside resistance genes in enterococci</article-title><source>Antimicrob Agents Chemother</source><year>2003</year><volume>47</volume><issue>4</issue><fpage>1423</fpage><lpage>1426</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXivVSms7c%3D</pub-id><pub-id pub-id-type="pmid">12654683</pub-id><pub-id pub-id-type="pmcid">152526</pub-id><pub-id pub-id-type="doi">10.1128/AAC.47.4.1423-1426.2003</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>JM</given-names></name><name><surname>Woo</surname><given-names>GJ</given-names></name></person-group><article-title xml:lang="en">Molecular characterization of high-level gentamicin-resistant <italic>Enterococcus faecalis</italic> from chicken meat in Korea</article-title><source>Int J Food Microbiol</source><year>2013</year><volume>165</volume><issue>1</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXovVeqsbY%3D</pub-id><pub-id pub-id-type="pmid">23685465</pub-id><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2013.02.016</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Talib</surname><given-names>H</given-names></name><name><surname>Zuraina</surname><given-names>N</given-names></name><name><surname>Kamarudin</surname><given-names>B</given-names></name><name><surname>Yean</surname><given-names>CY</given-names></name></person-group><article-title xml:lang="en">Genotypic variations of virulent genes in <italic>Enterococcus faecium</italic> and <italic>Enterococcus faecalis</italic> isolated from three hospitals in Malaysia</article-title><source>Adv Clin Exp Med</source><year>2015</year><volume>24</volume><issue>1</issue><fpage>121</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">25923096</pub-id><pub-id pub-id-type="doi">10.17219/acem/38162</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanos</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>DR</given-names></name></person-group><article-title xml:lang="en">Anti-listeria bacteriocin-producing bacteria from raw ewe's milk in northern Greece</article-title><source>J Appl Microbiol</source><year>2011</year><volume>110</volume><issue>3</issue><fpage>757</fpage><lpage>768</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXktVGnsrs%3D</pub-id><pub-id pub-id-type="pmid">21205100</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2672.2010.04932.x</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vuyst</surname><given-names>L</given-names></name><name><surname>Foulquie Moreno</surname><given-names>MR</given-names></name><name><surname>Revets</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Screening for enterocins and detection of hemolysin and vancomycin resistance in enterococci of different origins</article-title><source>Int J Food Microbiol</source><year>2003</year><volume>84</volume><issue>3</issue><fpage>299</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">12810293</pub-id><pub-id pub-id-type="doi">10.1016/S0168-1605(02)00425-7</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeighami</surname><given-names>H</given-names></name><name><surname>Valadkhani</surname><given-names>F</given-names></name><name><surname>Shapouri</surname><given-names>R</given-names></name><name><surname>Samadi</surname><given-names>E</given-names></name><name><surname>Haghi</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients</article-title><source>BMC Infect Dis</source><year>2019</year><volume>19</volume><fpage>629</fpage><pub-id pub-id-type="pmid">31315572</pub-id><pub-id pub-id-type="pmcid">6637494</pub-id><pub-id pub-id-type="doi">10.1186/s12879-019-4272-0</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldir</surname><given-names>G</given-names></name><name><surname>Ozturk Engin</surname><given-names>D</given-names></name><name><surname>Kucukercan</surname><given-names>M</given-names></name><name><surname>Inan</surname><given-names>A</given-names></name><name><surname>Akcay</surname><given-names>S</given-names></name><name><surname>Ozyurek</surname><given-names>S</given-names></name><name><surname>Aksaray</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">High level resistance to aminoglycoside, vancomycin and linezolid in enterococci strains</article-title><source>J Microbiol Infect Dis</source><year>2013</year><volume>3</volume><issue>3</issue><fpage>100</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.5799/ahinjs.02.2013.03.0090</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cekin</surname><given-names>Y</given-names></name><name><surname>Erman Daloğlu</surname><given-names>A</given-names></name><name><surname>Oğünç</surname><given-names>D</given-names></name><name><surname>Ozhak Baysan</surname><given-names>B</given-names></name><name><surname>Dağlar</surname><given-names>D</given-names></name><name><surname>Inan</surname><given-names>D</given-names></name><name><surname>Mutlu</surname><given-names>D</given-names></name><name><surname>Ongüt</surname><given-names>G</given-names></name><name><surname>Colak</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Evaluation of vancomycin resistance 3 multiplexed PCR assay for detection of vancomycin-resistant enterococci from rectal swabs</article-title><source>Ann Lab Med</source><year>2013</year><volume>33</volume><issue>5</issue><fpage>326</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">24003422</pub-id><pub-id pub-id-type="pmcid">3756236</pub-id><pub-id pub-id-type="doi">10.3343/alm.2013.33.5.326</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naserpour Farivar</surname><given-names>T</given-names></name><name><surname>Najafipour</surname><given-names>R</given-names></name><name><surname>Johari</surname><given-names>P</given-names></name><name><surname>Aslanimehr</surname><given-names>M</given-names></name><name><surname>Peymani</surname><given-names>A</given-names></name><name><surname>Jahani Hashemi</surname><given-names>H</given-names></name><name><surname>Mirzaui</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Development and evaluation of a Quadruplex Taq man real-time PCR assay for simultaneous detection of clinical isolates of E<italic>nterococcus faecalis, Enterococcus faecium</italic> and their vanA and vanB genotypes</article-title><source>Iranian J Microbiol</source><year>2014</year><volume>6</volume><issue>5</issue><fpage>335</fpage><lpage>340</lpage></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeighami</surname><given-names>H</given-names></name><name><surname>Haghi</surname><given-names>F</given-names></name><name><surname>Masumian</surname><given-names>N</given-names></name><name><surname>Hemmati</surname><given-names>F</given-names></name><name><surname>Samei</surname><given-names>A</given-names></name><name><surname>Naderi</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">Distribution of Integrons and gene cassettes among Uropathogenic and Diarrheagenic <italic>Escherichia coli</italic> isolates in Iran</article-title><source>Microb Drug Resist</source><year>2015</year><volume>21</volume><issue>4</issue><fpage>435</fpage><lpage>440</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXht1Kmsb3O</pub-id><pub-id pub-id-type="pmid">25658172</pub-id><pub-id pub-id-type="doi">10.1089/mdr.2014.0147</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kafil</surname><given-names>HS</given-names></name><name><surname>Asgharzadeh</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Vancomycin-resistant <italic>Enteroccus faecium</italic> and <italic>Enterococcus faecalis</italic> isolated from education hospital of Iran</article-title><source>Maedica</source><year>2014</year><volume>9</volume><issue>4</issue><fpage>323</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">25705299</pub-id><pub-id pub-id-type="pmcid">4316874</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padmasini</surname><given-names>E</given-names></name><name><surname>Padmaraj</surname><given-names>R</given-names></name><name><surname>Ramesh</surname><given-names>SS</given-names></name></person-group><article-title xml:lang="en">High level aminoglycoside resistance and distribution of aminoglycoside resistant genes among clinical isolates of Enterococcus species in Chennai, India</article-title><source>Sci World J</source><year>2014</year><volume>2014</volume><fpage>329157</fpage><pub-id pub-id-type="doi">10.1155/2014/329157</pub-id></mixed-citation></ref></ref-list></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>AAC</term><def><p id="Par5">Aminoglycoside acetyl transferase</p></def></def-item><def-item><term>AME</term><def><p id="Par6">Aminoglycoside modifying enzyme</p></def></def-item><def-item><term>ANT</term><def><p id="Par7">Aminoglycoside nucleotidyl transferase</p></def></def-item><def-item><term>APH</term><def><p id="Par8">Aminoglycoside phosphoryl transferase</p></def></def-item><def-item><term>ARG</term><def><p id="Par9">Aminoglycoside resistance gene;</p></def></def-item><def-item><term>HLAR</term><def><p id="Par10">High level aminoglycoside resistance</p></def></def-item><def-item><term>MDR</term><def><p id="Par11">Multidrug resistant</p></def></def-item><def-item><term>PYR</term><def><p id="Par12">L-Pyrrolidonyl-β-Naphthylamide</p></def></def-item><def-item><term>UTI</term><def><p id="Par13">Urinary tract infection</p></def></def-item><def-item><term>VRE</term><def><p id="Par14">Vancomycin resistant enterococci</p></def></def-item></def-list></glossary><notes notes-type="Misc"><title>Publisher’s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Infectious Diseases</facet-value><facet-value count="1">Internal Medicine</facet-value><facet-value count="1">Medical Microbiology</facet-value><facet-value count="1">Medicine &amp; Public Health</facet-value><facet-value count="1">Parasitology</facet-value><facet-value count="1">Tropical Medicine</facet-value></facet><facet name="keyword"><facet-value count="1">Aminoglycoside resistance</facet-value><facet-value count="1">Enterococci</facet-value><facet-value count="1">Vancomycin resistance</facet-value><facet-value count="1">Virulence factors</facet-value></facet><facet name="pub"><facet-value count="1">BMC Infectious Diseases</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">Iran</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
